Literature DB >> 15206930

Modulation of sarcoplasmic reticulum Ca(2+)-ATPase by chronic and acute exposure to peroxynitrite.

Yolanda Gutiérrez-Martín1, Francisco J Martín-Romero, Francisco A Iñesta-Vaquera, Carlos Gutiérrez-Merino, Fernando Henao.   

Abstract

The Ca(2+)-ATPase of skeletal muscle sarcoplasmic reticulum (SERCA), an integral membrane protein, becomes irreversibly inactivated in vitro by the addition of a single bolus of peroxynitrite with a K(0.5) of 200-300 microm, and this results in a large decrease of the ATP-dependent Ca2+ gradient across the sarcoplasmic reticulum (SR) membranes. The inactivation of SERCA is raised by treatment of SR vesicles with repetitive micromolar pulses of peroxynitrite. The inhibition of the SERCA is due to the oxidation of thiol groups and tyrosine nitration. Scavengers that react directly with peroxynitrite, such as cysteine, reduced glutathione, NADH, methionine, ascorbate or Trolox, a water-soluble analog of alpha-tocopherol, afforded significant protection. However, dimethyl sulfoxide and mannitol, two hydroxyl radical scavengers, and alpha-tocopherol did not protect SERCA from inactivation. Our results showed that the target of peroxynitrite is the cytosolic globular domain of the SERCA and that major skeletal muscle intracellular reductants (ascorbate, NADH and reduced glutathione) protected against inhibition of this ATPase by peroxynitrite.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15206930     DOI: 10.1111/j.1432-1033.2004.04193.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  14 in total

Review 1.  Mechanisms Explaining Muscle Fatigue and Muscle Pain in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a Review of Recent Findings.

Authors:  Morris Gerwyn; Michael Maes
Journal:  Curr Rheumatol Rep       Date:  2017-01       Impact factor: 4.592

2.  Rutin stimulates sarcoplasmic reticulum Ca(2+)-ATPase activity (SERCA1) and protects SERCA1 from peroxynitrite mediated injury.

Authors:  Jana Viskupicova; Miriam K Strosova; Petronela Zizkova; Magdalena Majekova; Lubica Horakova
Journal:  Mol Cell Biochem       Date:  2014-12-30       Impact factor: 3.396

3.  Inhibition of the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA1) by rutin derivatives.

Authors:  Jana Viskupicova; Magdalena Majekova; Lubica Horakova
Journal:  J Muscle Res Cell Motil       Date:  2014-12-03       Impact factor: 2.698

Review 4.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

5.  Reduction of AMP-activated protein kinase alpha2 increases endoplasmic reticulum stress and atherosclerosis in vivo.

Authors:  Yunzhou Dong; Miao Zhang; Bin Liang; Zhonglin Xie; Zhengxing Zhao; Sima Asfa; Hyoung Chul Choi; Ming-Hui Zou
Journal:  Circulation       Date:  2010-02-01       Impact factor: 29.690

6.  The reactive nitrogen species peroxynitrite is a potent inhibitor of renal Na-K-ATPase activity.

Authors:  Matthew S Reifenberger; Krista L Arnett; Craig Gatto; Mark A Milanick
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-13

Review 7.  Loss of endoplasmic reticulum Ca2+ homeostasis: contribution to neuronal cell death during cerebral ischemia.

Authors:  Ankur Bodalia; Hongbin Li; Michael F Jackson
Journal:  Acta Pharmacol Sin       Date:  2012-10-29       Impact factor: 6.150

Review 8.  Reactive oxygen species: impact on skeletal muscle.

Authors:  Scott K Powers; Li Li Ji; Andreas N Kavazis; Malcolm J Jackson
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

9.  CYP2J2-derived epoxyeicosatrienoic acids suppress endoplasmic reticulum stress in heart failure.

Authors:  Xingxu Wang; Li Ni; Lei Yang; Quanlu Duan; Chen Chen; Matthew L Edin; Darryl C Zeldin; Dao Wen Wang
Journal:  Mol Pharmacol       Date:  2013-10-21       Impact factor: 4.436

10.  CYP2E1 overexpression inhibits microsomal Ca2+-ATPase activity in HepG2 cells.

Authors:  Andres A Caro; Kerry L Evans; Arthur I Cederbaum
Journal:  Toxicology       Date:  2008-11-06       Impact factor: 4.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.